Giants of Cancer Care® Program Inductees

BREAST CANCER

Gabriel N. Hortobagyi, MD

The University of Texas MD Anderson Cancer Center

Developed and promoted the use of presurgical chemotherapy in patients with large tumors, reducing the tumors to 50% of their size prior to surgery and enabling subsequent surgical removal
Involved in the drug development of anthracyclines and taxanes in breast cancer therapy
Established the role of bisphosphonates in the management of bone metastases from breast cancer
Developed gene therapy approaches to breast cancer, and played a role in the initial development of gene expression profiling and its prognostic and predictive application in breast cancers
Past president of the American Society of Clinical Oncology
Chair of the Southwest Oncology Group since 2007
Recipient of numerous awards, including the 2012 William L. McGuire Award and Memorial Lecture, CTCR-AACR San Antonio Breast Cancer Symposium, and the 1997 Brinker International Award for Clinical Research

Home

)

SUPPORTED BY